| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,278 |
36,126 |
$2.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,138 |
11,615 |
$882K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,500 |
4,432 |
$393K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,087 |
2,585 |
$116K |
| 86328 |
|
2,061 |
1,937 |
$76K |
| 99215 |
Prolong outpt/office vis |
721 |
624 |
$62K |
| 99385 |
|
622 |
612 |
$58K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,607 |
1,524 |
$46K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
660 |
644 |
$46K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
471 |
465 |
$44K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
415 |
383 |
$37K |
| S9470 |
Nutritional counseling, dietitian visit |
503 |
462 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
631 |
608 |
$21K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
90 |
89 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,108 |
1,053 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
3,922 |
3,831 |
$15K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
54 |
13 |
$15K |
| 95117 |
|
1,485 |
440 |
$14K |
| 96160 |
|
4,889 |
4,828 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
828 |
799 |
$11K |
| 96127 |
|
2,627 |
2,556 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
487 |
461 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
503 |
456 |
$7K |
| 99000 |
|
1,700 |
1,499 |
$4K |
| 92551 |
|
388 |
383 |
$4K |
| 99492 |
|
50 |
50 |
$4K |
| 99442 |
|
182 |
167 |
$4K |
| 82962 |
|
1,660 |
1,488 |
$4K |
| 81002 |
|
955 |
877 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
250 |
237 |
$2K |
| 90686 |
|
222 |
181 |
$2K |
| 94760 |
|
2,940 |
2,103 |
$2K |
| 99173 |
|
787 |
739 |
$1K |
| 97802 |
|
118 |
107 |
$1K |
| 90656 |
|
42 |
42 |
$1K |
| 93000 |
|
82 |
80 |
$946.95 |
| 81025 |
|
166 |
144 |
$900.22 |
| H0001 |
Alcohol and/or drug assessment |
256 |
240 |
$835.87 |
| 90682 |
|
14 |
13 |
$490.06 |
| 90688 |
|
124 |
91 |
$372.54 |
| 94010 |
|
13 |
13 |
$335.16 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
45 |
36 |
$303.39 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$210.17 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
63 |
63 |
$133.13 |
| 86769 |
|
1,181 |
548 |
$117.43 |
| 85018 |
|
56 |
55 |
$92.65 |
| 36416 |
|
749 |
596 |
$40.59 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$8.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$4.38 |
| 3008F |
|
442 |
326 |
$0.04 |
| 1159F |
|
429 |
315 |
$0.04 |
| 1160F |
|
308 |
247 |
$0.03 |
| 4000F |
|
122 |
109 |
$0.01 |
| 3074F |
|
203 |
190 |
$0.00 |
| 3079F |
|
52 |
43 |
$0.00 |
| 1000F |
|
76 |
73 |
$0.00 |
| 86409 |
|
81 |
43 |
$0.00 |
| 87430 |
|
12 |
12 |
$0.00 |
| 3075F |
|
12 |
12 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
13 |
$0.00 |
| 3078F |
|
205 |
187 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
293 |
282 |
$0.00 |
| E0445 |
Oximeter device for measuring blood oxygen levels non-invasively |
79 |
51 |
$0.00 |